YangonineYangonin
A kava kavalactone, the only one of its family to bind CB1 (Ki = 0.72 µM), selective over CB2.
C₁₅H₁₄O₄
CAS 500-62-9
- Family
- PhytocannabinoidOutside cannabis
- Origin
- A plant other than hemp
- Molar mass
- 258.27 g/mol
Updated on
In plain terms
Yangonin is one of the kavalactones of kava, a traditional Pacific drink. Among the kavalactones tested, it is the only one that binds to the CB1 receptor. In rats, effects passing through this receptor were observed after injection near the spinal cord; no effect has been studied in humans.
Receptors and activity
Target network
- Binds or modulates
The lower the cited value, the closer the target sits to Yangonine: one ring per factor of 100. A target with no measured value stays on the edge.
Where these targets live
Where each target has been found in humans, according to the cited studies. The map shows the target, not an effect of Yangonine.
CB1CB1 found in 7 regions of the body
- Basal gangliadenseMost dense in basal ganglia outflow nuclei1
- CerebellumdenseVery dense in the cerebellum1
- HippocampusdenseVery high concentrations in the hippocampus2
- AmygdaladenseHigh concentrations in the amygdala2
- CortexpresentPresent throughout the neocortex2
- Adipose tissuepresentExpressed in adipose tissue3
- GutpresentColonic epithelium, smooth muscle and plexus4
Map sources
- Herkenham M et al. Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A, 1990 (new tab)
- Glass M et al. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience, 1997 (new tab)
- Engeli S et al. Activation of the peripheral endocannabinoid system in human obesity. Diabetes, 2005 (new tab)
- Wright K et al. Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing. Gastroenterology, 2005 (new tab)
Cited values
- CB1ModulatorKi = 720 nM · human36 out of 100
Ligresti et al. 2012, Pharmacol Res (new tab) · binding at recombinant human CB1; in vivo spinal effects blocked by the CB1 antagonist PF 514273 (Chow 2024); in vitro agonist activity not measured
- CB2Modulatorno measured value cited
Ki greater than 10 µM, recombinant human CB2 (Ligresti 2012)
Measured effects
Not characterised. No placebo-controlled human trial has measured the effects of Yangonine, so no level is shown.
Levels computed from placebo-controlled human trials: difference from placebo on 100, at the dose and route stated. Read the method
Pharmacology
Yangonin links two pharmacologies that are not spontaneously brought together. Kava, prepared from the roots of Piper methysticum, is consumed in the Pacific, and its active principles, the kavalactones, are polyketides whose scaffold is formed by styrylpyrone synthases (Pluskal 2019). In 2012, Ligresti and colleagues tested five natural kavalactones and nine synthetic analogues for their affinity at the cannabinoid receptors and their ability to inhibit FAAH and MAGL. A single molecule stood out, yangonin, with a Ki of 0.72 µM at the recombinant human CB1 receptor and selectivity over CB2 (Ki > 10 µM); no compound strongly inhibited the two enzymes. The authors conclude that the endocannabinoid system might contribute to the psychopharmacology of kava, and that the kavalactone scaffold offers an accessible framework for designing new ligands. In 2024, in rats, intrathecally injected yangonin (19.36 nmol) produced antinociception and reduced carrageenan inflammatory hyperalgesia, both effects fully reversed by a CB1 antagonist, without altering neuropathic mechanical allodynia; kavain, tested in parallel, had no effect (Chow 2024). No human data address this cannabinoid activity.
Key sources.
- Ligresti et al. 2012, Pharmacol Res: yangonin, a new CB1 receptor ligand (new tab)PMID 22525682
- Chow et al. 2024, J Ethnopharmacol: CB1-dependent spinal effects in the rat (new tab)PMID 38823663
- Pluskal et al. 2019, Nat Plants: biosynthetic origin of the kavalactones (new tab)PMID 31332312
- Teschke et al. 2011, Phytother Res: kava and hepatotoxicity (new tab)PMID 21442674
- Decision of 13 March 2003 (Afssaps) banning kava, JORF of 26 March 2003 (new tab)
History
- Source
- A kavalactone of kava (Piper methysticum), the shrub whose roots are used to prepare the traditional Pacific drink (Ligresti 2012; Chow 2024). It does not come from cannabis.
Biosynthetic pathway
A polyketide: in kava, a pair of paralogous styrylpyrone synthases establishes the common kavalactone scaffold (Pluskal 2019). This pathway has no connection with that of hemp cannabinoids.
Legal framework
- European Union
Neither yangonin nor kava appears in the schedules of the 1961 and 1971 United Nations conventions, and no European Union drug-control instrument covers them; the status of kava preparations is a matter for national authorities.
- France
Yangonin is not classified as a narcotic. However, the decision of 13 March 2003 of the director general of Afssaps prohibits the placing on the market, dispensing and therapeutic use of kava (Piper methysticum) and of products containing it, in all forms, except homeopathic medicines at dilutions equal to or above the 5th Hahnemannian centesimal dilution (JORF of 26 March 2003). The measure targets the plant and its preparations.
Sources: EUR-Lex, UNODC, CND, ANSM, IUPHAR/BPS, ChEBI, EUDA. Our method.
Classification
Family, origin and source verification
- Family
Phytocannabinoid › Outside cannabis
- Presence in the plant
Made by an organism other than cannabis
- Chemistry
Kavalactone (styrylpyrone)
- Verification
Every fact on this entry was checked against its primary sources on 20 October 2026.
- Wikipedia (English)
Article paired by the molecule's structure (InChIKey), revision read on 19 October 2026. Read as a second opinion, never cited as a source.
References
- Ligresti et al. 2012, Pharmacol Res: yangonin, a new CB1 receptor ligand (new tab)PMID 22525682
- Chow et al. 2024, J Ethnopharmacol: CB1-dependent spinal effects in the rat (new tab)PMID 38823663
- Pluskal et al. 2019, Nat Plants: biosynthetic origin of the kavalactones (new tab)PMID 31332312
- Teschke et al. 2011, Phytother Res: kava and hepatotoxicity (new tab)PMID 21442674
- Decision of 13 March 2003 (Afssaps) banning kava, JORF of 26 March 2003 (new tab)
Identifiers
Names
- Common name
- Yangonin
- IUPAC name
- 4-methoxy-6-[(E)-2-(4-methoxyphenyl)ethenyl]pyran-2-one
- Other names
- Yagonine
Identifiers
- Formula
- C₁₅H₁₄O₄
- CAS
- 500-62-9
- PubChem CID
- 5281575(new tab)
- ChEBI
- 10089(new tab)
- InChIKey
- XLHIYUYCSMZCCC-VMPITWQZSA-N
- SMILES
- COC1=
CC= C(C= C1) /C= C/C2= CC(= CC(= O) O2) OC
LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.